Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sham Mailankody

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Blood|July 13, 2013
MGUS prevalence in a cohort of AML patientsS Peter Wu, Rene Costello, Jonathan N Hofmann, et al.
Nature Reviews. Clinical Oncology|January 28, 2015
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Neha Korde, Alexander M Lesokhin, et al.
European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.
American Journal of Hematology|May 19, 2020
Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?Tamara Nawar, Sejal Morjaria, Anna Kaltsas, et al.
Blood|July 29, 2011
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
Clinical Pharmacology and Therapeutics|June 27, 2026
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World DataVasiliki Kostiou, Vijayalakshmi Chelliah, Piet H van der Graaf, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2017
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphismsTristan M Sissung, Cody J Peer, Neha Korde, et al.
JAMA Oncology|July 17, 2015
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple MyelomaElin Edda Sigurdardottir, Ingemar Turesson, Sigrun Helga Lund, et al.
Haematologica|December 19, 2015
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical TrialsBruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Blood|July 13, 2013
MGUS prevalence in a cohort of AML patientsS Peter Wu, Rene Costello, Jonathan N Hofmann, et al.
Nature Reviews. Clinical Oncology|January 28, 2015
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Neha Korde, Alexander M Lesokhin, et al.
European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.
American Journal of Hematology|May 19, 2020
Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?Tamara Nawar, Sejal Morjaria, Anna Kaltsas, et al.
Blood|July 29, 2011
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
Clinical Pharmacology and Therapeutics|June 27, 2026
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World DataVasiliki Kostiou, Vijayalakshmi Chelliah, Piet H van der Graaf, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2017
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphismsTristan M Sissung, Cody J Peer, Neha Korde, et al.
JAMA Oncology|July 17, 2015
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple MyelomaElin Edda Sigurdardottir, Ingemar Turesson, Sigrun Helga Lund, et al.
Haematologica|December 19, 2015
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical TrialsBruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, et al.
Pageof 18